Assessing multiple-choice question quality in internal medicine: a comparative analysis of three large language models against expert consensus

• by Mevlüt Okan Aydin, Belkıs Nihan Coşkun, İbrahim Hamal

• July 9, 2026

Can Belzutifan Improve Adjuvant Therapy?

The phase 3 LITESPARK-022 trial compared adjuvant pembrolizumab plus belzutifan with pembrolizumab plus placebo following resection of clear-cell renal-cell carcinoma.

• by Kathryn Wighton

• July 8, 2026

• 4 min

Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure

• by Joachim Boldt

• July 9, 2026

Core muscle rehabilitation during early mobilization after stroke: a narrative review and clinical framework

• by Chang-lan Ling-hu, Qin Yu, Meng Li, Zhen-zhen Liu, Xia-pei Peng

• July 9, 2026